(R)-N-(2-amino-5,5-difluoro-5,6-dihydrospiro[[1,3]oxazine-4,4'-thiochroman]-6'-yl)-5-cyanopicolinamide | 1415108-01-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并硫平类
• 英文名称: (R)-N-(2-amino-5,5-difluoro-5,6-dihydrospiro[[1,3]oxazine-4,4'-thiochroman]-6'-yl)-5-cyanopicolinamide
• 英文别名: N-[(4R)-2'-amino-5',5'-difluorospiro[2,3-dihydrothiochromene-4,4'-6H-1,3-oxazine]-6-yl]-5-cyanopyridine-2-carboxamide
• CAS: 1415108-01-8
• 化学式: C₁₉H₁₅F₂N₅O₂S
• 分子量: 415.423
• InChiKey: QEJNOHUVEOEPMO-GOSISDBHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  29
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.26
• 拓扑面积：
  139
• 氢给体数：
  2
• 氢受体数：
  8

文献信息

• SPIRO-[1,3]-OXAZINES AND SPIRO-[1,4]-OXAZEPINES AS BACE1 AND/OR BACE2 INHIBITORS
  申请人：Narquizian Robert

  公开号：US20120302549A1

  公开（公告）日：2012-11-29

  The present invention provides spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines of formula I having BACE1 and/or BACE2 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease and type 2 diabetes.

  本发明提供了具有BACE1和/或BACE2抑制活性的式I的螺[1,3]-噁唑和螺[1,4]-噁唑环烯化合物，其制备方法，包含它们的药物组合物以及它们作为治疗活性物质的用途。本发明的活性化合物在治疗和/或预防治疗例如阿尔茨海默病和2型糖尿病等疾病方面非常有用。
• SYNTHETIC INTERMEDIATE OF OXAZOLE COMPOUND AND METHOD FOR PRODUCING THE SAME
  申请人：Yamamoto Akihiro

  公开号：US20120302757A1

  公开（公告）日：2012-11-29

  An object of the present invention is to provide a method for producing an oxazole compound in a high yield. The object can be achieved by a compound represented by Formula (11): wherein R 1 is a hydrogen atom or lower-alkyl group; R 2 is a 1-piperidyl group substituted at the 4-position with a substituent selected from (A1a) a phenoxy group substituted on the phenyl moiety with one or more halogen-substituted lower-alkoxy groups, (A1b) a phenoxy-substituted lower-alkyl group substituted on the phenyl moiety with one or more halogen-substituted lower-alkyl groups, (A1c) a phenyl-substituted lower-alkoxy lower-alkyl group substituted on the phenyl moiety with halogen, (A1d) a phenyl-substituted lower-alkyl group substituted on the phenyl moiety with one or more halogen-substituted lower-alkoxy groups, (A1e) an amino group substituted with a phenyl group substituted with one or more halogen-substituted lower-alkoxy groups, and a lower-alkyl group, and (A1f) a phenyl-substituted lower-alkoxy group substituted on the phenyl moiety with one or more halogen-substituted lower-alkoxy groups; n is an integer from 1 to 6; and X 3 is an organic sulfonyloxy group.

  本发明的目的是提供一种高产率制备噁唑化合物的方法。该目的可以通过式（11）表示的化合物实现：其中R1是氢原子或低烷基基团；R2是在4-位被取代的1-哌啶基团，所述取代基被选择自（A1a）在苯基上取代一个或多个卤素取代低烷氧基的苯氧基，（A1b）在苯基上取代一个或多个卤素取代低烷基的苯氧基取代低烷基基团，（A1c）在苯基上取代卤素的苯基取代低烷氧基低烷基基团，（A1d）在苯基上取代一个或多个卤素取代低烷氧基的苯基取代低烷基基团，（A1e）取代有苯基的氨基取代一个或多个卤素取代低烷氧基的苯基和低烷基基团，以及（A1f）在苯基上取代一个或多个卤素取代低烷氧基的苯基取代低烷氧基基团；n是1到6的整数；X3是有机磺酰氧基团。
• US8598358B2
  申请人：——

  公开号：US8598358B2

  公开（公告）日：2013-12-03
• US9079919B2
  申请人：——

  公开号：US9079919B2

  公开（公告）日：2015-07-14